Research Topics
| E V NunesSummaryAffiliation: Columbia University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Treatment of depression in patients with alcohol or other drug dependence: a meta-analysisEdward V Nunes
Depression Evaluation Service, New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York 10032, USA
JAMA 291:1887-96. 2004..Depression and substance abuse are common and costly disorders that frequently co-occur, but controversy about effective treatment for patients with both disorders persists...- Treatment of depression in patients with opiate dependenceEdward V Nunes
New York State Psychiatric Institute, and Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Biol Psychiatry 56:793-802. 2004..Research is needed on such integrated models of care and treatment algorithms to determine their efficacy and cost effectiveness... - Clinical and translational research: introduction to the special issueEdward V Nunes
Department of Psychiatry, Columbia University College of Physicians and Surgeons, USA
Exp Clin Psychopharmacol 10:155-8. 2002.... 
Baseline matters: the importance of covariation for baseline severity in the analysis of clinical trialsEdward V Nunes
Department of Psychiatry, Columbia University, New York State Psychiatric Institute, NY 10032, USA
Am J Drug Alcohol Abuse 37:446-52. 2011..Such trials are expensive and time-consuming to conduct, but the underlying effect sizes tend to be modest, and often findings are disappointing, failing to show evidence of treatment effects...- Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-VEdward V Nunes
New York State Psychiatric Institute and Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, USA
Addiction 101:89-96. 2006..To arrive at recommendations for addressing co-occurring psychiatric and substance use disorders in the development of the Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-V) criteria... - Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?Edward V Nunes
Columbia University Department of Psychiatry, New York State Psychiatric Institute, National Drug Abuse Clinical Trials Network, Long Island Node, New York, NY, USA
J Subst Abuse Treat 38:S97-112. 2010..Based on this review, recommendations are generated to inform the design of future effectiveness trials on treatments for substance abuse, HIV risk, and other behavioral health problems... - Psychiatric disorders and impairment in the children of opiate addicts: prevalances and distribution by ethnicityE V Nunes
Depression Evaluation Service, New York State Psychiatric Institute, NY 10032, USA
Am J Addict 9:232-41. 2000..The results suggest children of patients in treatment for opiate dependence from diverse ethnic groups are at risk for psychopathology. Programs for early detection and intervention should be devised and evaluated... - Treating depression in substance abusersEdward V Nunes
New York State Psychiatric Institute, 1051 Riverside Drive Unit 51, New York, NY 10032, USA
Curr Psychiatry Rep 8:363-70. 2006.... - Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-upEdward V Nunes
Department of Psychiatry, College of Physicians and Surgeons, New York State Psychiatric Institute, NY, USA
J Clin Psychiatry 67:1561-7. 2006..The authors examined whether baseline and past diagnoses of DSM-IV primary (independent) or substance-induced depression or other psychiatric syndromes predict 1-year course of depression in substance-dependent patients... - Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?Edward V Nunes
New York State Psychiatric Institute, Division on Substance Abuse, New York, New York 10032, USA
Am J Drug Alcohol Abuse 32:503-17. 2006..Future research should consider combinations of behavioral methods with new long-acting injectable or implantable naltrexone formulations... - Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trialDavid McDowell
Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
Drug Alcohol Depend 80:209-21. 2005..Future research should examine newer antidepressant medications with more benign side effect profiles and combinations of behavioral and pharmacological treatments to maximize effects on cocaine use... - Using buprenorphine to facilitate entry into residential therapeutic community rehabilitationEric D Collins
Department of Psychiatry, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
J Subst Abuse Treat 32:167-75. 2007..The findings suggest the potential for buprenorphine to serve as a bridge, improving the viability of long-term residential treatment for managing opioid dependence... - Psychopathology in children of parents with opiate dependence and/or major depressionE V Nunes
Department of Genetic Epidemiology, New York State Psychiatric Institute, NY 10032, USA
J Am Acad Child Adolesc Psychiatry 37:1142-51. 1998..To evaluate psychiatric disorders and impairment in school-age and adolescent children of opiate-dependent patients... - Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesisE Aharonovich
Division on Substance Abuse Substance Treatment and Research Services, New York State Psychiatric Institute, New York City 10032, USA
Am J Addict 10:327-34. 2001..Data are discussed in terms of diagnosis and clinical treatment implications... - Suicide risk in depressed methadone-maintained patients: associations with clinical and demographic characteristicsJordana Phillips
University of Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA
Am J Addict 13:327-32. 2004..When evaluating opiate-dependent patients with depressive disorders, these features should be considered in efforts to identify those at heightened risk for suicide and plan interventions... - Substance use, childhood sexual abuse, and sexual risk behavior among women in methadone treatmentLisa R Cohen
Department of Psychiatry, Columbia University Medical Center, New York, New York, USA lc21302columbia edu
Am J Drug Alcohol Abuse 35:305-10. 2009..Substance use and a history of childhood sexual abuse (CSA) are risk factors for unprotected sex among women, yet questions remain as to how their combined influence may differentially affect sexual risk... - Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related ConditionsAnalucia A Alegria
New York State Psychiatric Institute, New York, USA
J Clin Psychiatry 71:1187-95; quiz 1252-3. 2010.... 
DSM-IV criteria-based clinical subtypes of cannabis use disorders: results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC)Carlos Blanco
New York State Psychiatric Institute, New York, NY 10032, USA
Drug Alcohol Depend 96:136-44. 2008..Future research should investigate whether there are differences in the course and treatment response of these clinical subtypes of cannabis use disorders, and the heterogeneity of other substance use disorders...- The effect of sertraline on methadone plasma levels in methadone-maintenance patientsS P Hamilton
Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, NY 10032, USA
Am J Addict 9:63-9. 2000..Clinicians treating depressed or anxious methadone patients with second-generation antidepressants should monitor for clinical signs of increased or decreased methadone levels and consider monitoring serum methadone levels... - Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcomeEfrat Aharonovich
Columbia University, Department of Psychiatry, College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, USA
Drug Alcohol Depend 95:279-83. 2008..If supported by further studies, the findings may help inform the development of interventions tailored for cognitively impaired marijuana-dependent patients... - Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependenceNehal P Vadhan
Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, Columbia University New York, New York 10032, USA
Am J Drug Alcohol Abuse 33:727-36. 2007..The purpose of this study was to compare attentional bias towards cocaine-related verbal stimuli between treatment-seeking and nontreatment-seeking cocaine abusers... - Developing therapies for depression in drug dependence: results of a stage 1 therapy studyKenneth M Carpenter
New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York, New York, USA
Am J Drug Alcohol Abuse 34:642-52. 2008.... - A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in periodAdam Bisaga
Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
Drug Alcohol Depend 111:97-104. 2010..Targeting the latter subgroup may advance medication development efforts... - OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differencesLirio S Covey
New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Drive, New York, NY 10032, United States
Drug Alcohol Depend 110:156-9. 2010..To explore racial/ethnic difference in OROS-methylphenidate (OMPH) efficacy when added to nicotine patch and counseling for treating nicotine dependence among smokers with attention deficit hyperactivity disorder (ADHD)... - Early abstinence in cocaine dependence: influence of comorbid major depressionEric Rubin
Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, Columbia University, New York, New York 10032, USA
Am J Addict 16:283-90. 2007..By Day 3, BDI scores improved for both CD and CD + MDD groups. The mood response to cocaine cessation among CD + MDD individuals resembled that of CD participants, contrary to some expectations... - Dextromethorphan and quinidine combination for heroin detoxificationEvaristo Akerele
Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA
Am J Addict 17:176-80. 2008..Future studies should examine dextromethorphan as an adjunct to other anti-withdrawal medications and focus more on the relationship between dextrorphan levels and withdrawal suppression... - Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related ConditionsCarlos Blanco
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA
J Clin Psychiatry 69:1276-80. 2008..The goal of this study was to assess the proportion of community-dwelling adults with major depressive episode (MDE) who would meet eligibility criteria for a traditional efficacy trial in patients with MDE... - Generalizability of clinical trials for alcohol dependence to community samplesCarlos Blanco
New York State Psychiatric Institute Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Box 69, New York, NY 10032, United States
Drug Alcohol Depend 98:123-8. 2008..Clinical trials should carefully evaluate the effects of the selected eligibility criteria on the generalizability of their results... - Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials NetworkDenise A Hien
City College of New York, North Academic Campus, 160 Convent Ave, New York, NY 10030, USA
Am J Psychiatry 167:95-101. 2010..The purpose of the analysis was to examine the temporal course of improvement in symptoms of posttraumatic stress disorder (PTSD) and substance use disorder among women in outpatient substance abuse treatment... - Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disordersDenise A Hien
Department of Psychology, City University of New York, City College of New York, New York, NY 10030, USA
J Consult Clin Psychol 77:607-19. 2009.... - Relationship power and sexual risk among women in community-based substance abuse treatmentAimee N C Campbell
Substance Abuse Division, New York State Psychiatric Institute, New York, NY 10032, USA
J Urban Health 86:951-64. 2009..Possible explanations for these findings are discussed, and future research directions for examining power constructs and developing interventions targeting relationship power among drug-involved women are suggested... - The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site studyDenise A Hien
Department of Psychology, City College of New York, City University of New York, North Academic Campus Room 8 131, 138th Street and Convent Avenue, New York, NY 10030, USA
AIDS Behav 14:421-30. 2010..High risk women with co-occurring PTSD and addiction may benefit from treatment addressing coping skills and trauma to reduce HIV risk... - Substance use and high risk sexual behaviors among women in psychosocial outpatient and methadone maintenance treatment programsSusan Tross
Columbia University Medical Center, Department of Psychiatry, USA
Am J Drug Alcohol Abuse 35:368-74. 2009.... - Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependenceWilfrid Noel Raby
Division on Substance Abuse, Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA
Am J Addict 18:301-8. 2009..Experimental studies are needed to directly test the hypothesis that cannabinoid agonists exert a beneficial pharmacological effect on naltrexone maintenance and to understand the mechanism... - Betting on change: modeling transitional probabilities to guide therapy development for opioid dependenceKenneth M Carpenter
Division on Substance Abuse, New York State Psychiatric Institute, USA
Psychol Addict Behav 23:47-55. 2009..PsycINFO Database Record (c) 2009 APA, all rights reserved)... - Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot studyMartin C McElhiney
Therapeutics, New York State Psychiatric Institute, New York, New York, USA
Am J Drug Alcohol Abuse 35:34-7. 2009..To evaluate the efficacy of modafinil combined with cognitive behavioral therapy (CBT) for treatment of methamphetamine (MA) dependence among HIV+ gay men... - Cognition, commitment language, and behavioral change among cocaine-dependent patientsEfrat Aharonovich
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
Psychol Addict Behav 22:557-62. 2008..Future clinical studies should further investigate the relations between cognition and commitment to change and their differential contributions to treatment processes and outcome... - Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network TrialSusan Tross
Department of Psychiatry, HIV Center for Clinical and Behavioral Studies, Columbia University Medical Center, New York, NY 10032, USA
J Acquir Immune Defic Syndr 48:581-9. 2008..Because drug-involved women are among the fastest growing groups with AIDS, sexual risk reduction intervention for them is a public health imperative... - Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependenceFrances R Levin
New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York, NY, USA
J Subst Abuse Treat 34:80-9. 2008.... - Cognitive deficits predict low treatment retention in cocaine dependent patientsEfrat Aharonovich
College of Physicians and Surgeons, Department of Psychiatry, Columbia University, Division on Substance Abuse, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
Drug Alcohol Depend 81:313-22. 2006..Modified behavioral and pharmacologic interventions should be considered to target mild cognitive impairments to improve substance treatment outcome... - A randomized placebo-controlled trial of gabapentin for cocaine dependenceAdam Bisaga
Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
Drug Alcohol Depend 81:267-74. 2006..Gabapentin is an anticonvulsant medication that increases human brain GABA levels. We evaluated the safety and efficacy of gabapentin combined with relapse-prevention therapy in the treatment of cocaine-dependent individuals... - Education and training in psychopharmacologyCarlos Blanco
Department of Psychiatry, Columbia University. 1051 Riverside Dr, Box 69, New York, New York 10032, USA
Acad Psychiatry 29:124-7. 2005 - Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patientsWilfrid Noel Raby
Substance Treatment and Research Service S T A R S, Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, NYC, NY 10032, USA
Drug Alcohol Depend 81:283-92. 2006..These results suggest that temperament dimensions may be important for identifying substance dependent patients more likely to benefit from pharmacological interventions for comorbid depressive disorders... - Utility of lead-in period in cocaine dependence pharmacotherapy trialsAdam Bisaga
Department of Psychiatry, Columbia University College of Physicians and Surgeons, NY, USA
Drug Alcohol Depend 77:7-11. 2005..Findings of this study suggest that route and level of cocaine use during lead-in be used as a covariate in models testing treatment effect... - Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trialMaria A Sullivan
Department of Psychiatry, New York State Psychiatric Institute, New York, NY, USA
Am J Addict 15:150-9. 2006.... - Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekersFrances R Levin
New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
J Addict Dis 25:33-41. 2006.... - Verbal abilities as predictors of retention among adolescents in a therapeutic communityJeffrey J Wilson
Department of Psychiatry, Division on Substance Abuse, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, 1051 Riverside Drive, Box 66, New York, NY 10032, USA
Child Psychiatry Hum Dev 36:393-401. 2006..Remediation of verbal communication skills may be an overlooked aspect of the therapeutic process in treating adolescent substance abusers... - Behavior therapy for depression in drug dependence (BTDD): results of a stage Ia therapy development pilotKenneth M Carpenter
Division on Substance Abuse, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Am J Drug Alcohol Abuse 32:541-8. 2006..There were no changes in opiate and cocaine use. BTDD may be a useful adjunct to methadone maintenance for treating comorbid depressive disorders... - Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcomeEfrat Aharonovich
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, USA
Am J Drug Alcohol Abuse 32:629-35. 2006..02). This study is the first to examine concurrent cannabis use in cocaine dependent patients diagnosed with ADHD... - The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trialKenneth M Carpenter
Division on Substance Abuse, New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, 1051 Riverside Drive, Box 120, New York, NY, 10032, USA
Drug Alcohol Depend 74:123-34. 2004..They also suggest future research should examine a pharmacological treatment that is combined with a behavioral intervention targeting the accessibility of reinforcement or reducing the impact of aversive environmental interactions... - Management of relapse in naltrexone maintenance for heroin dependenceMaria A Sullivan
College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
Drug Alcohol Depend 91:289-92. 2007..Time retained in treatment was examined as a function of whether lapses to opioid use occurred while adherent to naltrexone (blocked use), or after having missed naltrexone doses (unblocked)... - Neurological soft signs and disruptive behavior among children of opiate dependent parentsJeffrey J Wilson
Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA
Child Psychiatry Hum Dev 34:19-34. 2003.... - Behavioral naltrexone therapy: an integrated treatment for opiate dependenceJami L Rothenberg
The New York State Psychiatric Institute, Division on Substance Abuse, Substance Treatment and Research Service, 1051 Riverside Drive, New York, NY 10032, USA
J Subst Abuse Treat 23:351-60. 2002..Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted... - Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placeboFrances R Levin
New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
Drug Alcohol Depend 81:137-48. 2006..Taken together, sustained-release methylphenidate or sustained-release bupropion did not provide a clear advantage over placebo in reducing ADHD symptoms or additional cocaine use in methadone-maintained patients... - Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependenceS H Church
New York State Psychiatric Institute, Substance Treatment and Research Service, New York 10032, USA
Am J Drug Alcohol Abuse 27:441-52. 2001..Further research is needed to identify the optimal therapeutic stance toward other drug use during treatment for opiate dependence... - Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover designS J Donovan
Department of Therapeutics, Division of Epidemiology of Brain Disorders, New York State Psychiatric Institute, New York, NY 10032, USA
Am J Psychiatry 157:818-20. 2000..The authors sought to replicate open-label findings showing that specific criteria for explosive temper and mood lability identify disruptive youth who improve while receiving the anticonvulsant divalproex sodium... - Pergolide mesylate for cocaine abuse: a controlled preliminary trialF R Levin
Department of Psychiatry, Columbia University New York State Psychiatric Institute, NY 10032, USA
Am J Addict 8:120-7. 1999..Comparing an agent to both an active control and placebo group may better predict whether a promising new agent will have clinical utility compared to the standard open trial... - Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research ProgramJ W Stewart
New York State Psychiatric Institute, New York, USA
J Clin Psychopharmacol 18:429-34. 1998..Failure to identify this subtype underestimates imipramine's benefit in the appropriately treated subgroup. Comparisons of other treatments with imipramine may be misleading if they do not account for diagnostic subtype... - Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to actionDennis S Charney
Department of Psychiatry, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104-6178, USA
Biol Psychiatry 56:703-13. 2004 - Smoking cessation treatment in community-based substance abuse rehabilitation programsMalcolm S Reid
Department of Psychiatry, New York University School of Medicine, New York, NY, USA
J Subst Abuse Treat 35:68-77. 2008..Substance abuse treatment programs should not hesitate to implement SC for established patients... - Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002Carlos Blanco
Department of Epidemiology, Columbia University and the New York State Psychiatric Institute, New York, NY 10032, United States
Drug Alcohol Depend 90:252-60. 2007..To examine changes in the prevalence of non-medical prescription drug use and DSM-IV non-medical prescription abuse and dependence in the United States between 1991-1992 and 2001-2002... - "Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?Stephen J Donovan
Department of Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA
J Clin Psychiatry 64:698-701. 2003.... - Pathological gambling: addiction or compulsion?C Blanco
Department of Psychiatry, Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
Semin Clin Neuropsychiatry 6:167-76. 2001..Improved understanding of the conceptualization of this disorder may help improve the quality of the treatments available... - Generalizability of clinical trials for cannabis dependence to community samplesMayumi Okuda
New York State Psychiatric Institute Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
Drug Alcohol Depend 111:177-81. 2010..Clinical trials should carefully evaluate the effects of eligibility criteria on the generalizability of their results. Even in efficacy trials, stringent exclusionary criteria could limit the representativeness of study results... - Providing live supervision via teleconferencing improves acquisition of motivational interviewing skills after workshop attendanceJennifer L Smith
Montclair State University, Montclair, New Jersey, USA
Am J Drug Alcohol Abuse 33:163-8. 2007..Teleconferencing Supervision may help facilitate the proficient use of MI community clinicians following workshop instruction... - Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefsDennis McCarty
Department of Public Health and Preventive Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA
Psychiatr Serv 58:181-90. 2007..Individuals with direct care responsibilities in 348 drug abuse treatment units were surveyed to obtain a description of the workforce and to assess support for evidence-based therapies... - Treatment programs in the National Drug Abuse Treatment Clinical Trials NetworkDennis McCarty
Oregon Health and Science University, 3181 SW Sam Jackson Park Road, CB669, Portland, OR 97239, USA
Drug Alcohol Depend 92:200-7. 2008..Conversely, programs with accreditation had less social model influence. The CTN is an ambitious effort to engage community-based treatment organizations into research and more fully integrate research and practice... - New-onset mania and psychosis following heroin detoxification and naltrexone maintenanceMaria A Sullivan
Am J Addict 14:486-7. 2005 - Genomewide suggestive linkage of opioid dependence to chromosome 14qHerbert M Lachman
Division of Basic Research, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of MedicineBronx, NY 10461, USA
Hum Mol Genet 16:1327-34. 2007..05). Our linkage data suggest specific chromosomal loci for future fine-mapping genetic analysis and support the hypothesis that ethnic and gender specific genes underlie addiction susceptibility... - Organizational Readiness for Change and opinions toward treatment innovationsBret E Fuller
Oregon Health and Science University, Portland, OR 97239, USA
J Subst Abuse Treat 33:183-92. 2007..The analysis provides evidence of the ORC's utility in assessing agency strengths and needs during the implementation of evidence-based practices...
Research Grants
- MI Training: Live Supervision by Tele-ConferenceEdward Nunes; Fiscal Year: 2006..It is hypothesized that counselors trained with TCS-MI will achieve superior MI skills, as measured by the Motivational Interview Skill Coding (MISC) system, compared to controls. ..
- Drug Abuse Treatment Development and Research MentoringEdward Nunes; Fiscal Year: 2007..The ultimate goals are to improve the treatment of drug dependent patients through clinical research and to help foster the next generation of clinician-researchers. ..
- OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPYMaria Sullivan; Fiscal Year: 2007....
- Clinical Trials Network: Long Island Regional NodeEdward Nunes; Fiscal Year: 2007..We will also continue to encourage and seek outside funding for studies conducted on the CTN platform. ..
- CU PARTNERS: NY/LONG ISLAND REGIONAL NODEEdward Nunes; Fiscal Year: 2007..abstract_text> ..
- Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment SiteEdward V Nunes; Fiscal Year: 2010..The data from this study can also be used by the FDA to evaluate the benefits of this treatment that could improve the lives of patients suffering from opioid addiction. ..
- OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPYEdward Nunes; Fiscal Year: 2004....
- DRUG ABUSE PHARMACOTHERAPY: METHODOLOGIC INITIATIVESEdward Nunes; Fiscal Year: 2005..The applicant will continue to pursue a training plan focused on methodology and statistics of clinical trials, behavioral interventions, and the responsible conduct of research. ..
- BEHAVIORAL THERAPY FOR DEPRESSION IN DRUG DEPENDENCEEdward Nunes; Fiscal Year: 2002..3. To test the theory that an increase in response-contingent reinforcement will produce an improvement in depression and reduced drug use. ..
- CU PARTNERS: NY/LONG ISLAND REGIONAL NODEEdward Nunes; Fiscal Year: 2005..abstract_text> ..
- Training Motivational Interviewing Using Live SupervisionEdward V Nunes; Fiscal Year: 2010..This could have considerable potential to promote the adoption of new treatments into real-world practice, improving the quality of the clinical workforce and the quality of care delivered in the substance abuse treatment system. ..